Skip to main content
Clinical Trials/ISRCTN97686858
ISRCTN97686858
Completed
Not Applicable

A randomized, controlled study of intra-articular injections of etanercept or glucocorticosteroids in patients with rheumatoid arthritis

The Parker Institute (Denmark)0 sites38 target enrollmentJuly 19, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
The Parker Institute (Denmark)
Enrollment
38
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Parker Institute (Denmark)

Eligibility Criteria

Inclusion Criteria

  • Rheumatoid arthritis (RA), age \>18 years, written informed consent, flare of RA in wrist, elbow, or knee joint

Exclusion Criteria

  • Systemic anti tumour necrosis factor (TNF) alpha therapy, had had intra\-articular injection of steroids in the joint within 3 months, had skin lesions or other disease associated with increased risk of infection after injection, malignancy, severe heart, kidney, and/or lung disease, infections including human immunodeficiency virus (HIV), elevated alanine aminotransferase (ALT) (twice above the reference range), creatinine (\>175 mmol/l), leucopenia (\<3\.5 x 10^9/l), thrombocytopenia (\<125 x 10^9/l), or hemoglobin \<8\.5 g/dl, or allergy to the injected compounds. Women were excluded if pregnant, or of childbearing potential with an unacceptable birth control method.

Outcomes

Primary Outcomes

Not specified

Similar Trials